Treatment of follicular Lymphoma B-cell with rituximab

被引：0
|
作者：
Petryk, Gwen [1 ]
机构：
[1] Cross Canc Inst, Serv Sante Alberta, Edmonton, AB, Canada
来源：
CANADIAN PHARMACISTS JOURNAL | 2010年 / 143卷
关键词：
D O I：
10.3821/1913-701X-143.sp1.S5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：S5 / +
页数：3
相关论文
共 50 条
  • [11] Treatment of Indolent Cutaneous B-Cell Lymphoma with Intralesional or Intravenous Rituximab
    Menzer, Christian
    Rendon, Adriana
    Hassel, Jessica C.
    CANCERS, 2022, 14 (19)
  • [12] Mechanism and Treatment of Rituximab Resistance in Diffuse Large B-cell Lymphoma
    Zou, Linqing
    Song, Guoqi
    Gu, Siyu
    Kong, Lingling
    Sun, Shiqi
    Yang, Li
    Cho, William C.
    CURRENT CANCER DRUG TARGETS, 2019, 19 (09) : 681 - 687
  • [13] Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung
    Aviles, Agustin
    Nambo, Maria J.
    Huerta-Guzman, Judith
    Silva, Luis
    Neri, Natividad
    HEMATOLOGY, 2013, 18 (02) : 81 - 84
  • [14] Intralesional and systemic rituximab in the treatment of primary cutaneous B-cell lymphoma
    Besch-Stokes, Jake G.
    Shahin, Ahmad
    Bhullar, Puneet
    Hwang, Angelina
    Kechter, Jacob
    Puri, Pranav
    Butterfield, Richard
    Costello, Collin
    Rule, William G.
    Rosenthal, Allison
    Dicaudo, David J.
    Pittelkow, Mark R.
    Mangold, Aaron R.
    JEADV CLINICAL PRACTICE, 2023, 2 (04): : 872 - 881
  • [15] The rapidly expanding role of rituximab in the treatment of aggressive B-cell lymphoma
    Cooper, D
    CANCER JOURNAL, 2002, 8 (05): : 364 - 366
  • [16] Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphoma
    Chirico, A.
    Henderson Berg, M. H.
    Roberge, D.
    Pehr, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (02) : 354 - 356
  • [17] Rituximab in treatment of primary gastric diffuse large B-cell lymphoma
    Zhang, Jian
    Li, Gang
    Yang, Haiyan
    Liu, Xiaojian
    Cao, Junning
    LEUKEMIA & LYMPHOMA, 2012, 53 (11) : 2175 - 2181
  • [18] Re-treatment of relapsed indolent B-cell lymphoma with rituximab
    Igarashi, T
    Ohtsu, T
    Fujii, H
    Sasaki, Y
    Morishima, Y
    Ogura, M
    Kagami, Y
    Kinoshita, T
    Kasai, M
    Kiyama, Y
    Kobayashi, Y
    Tobinai, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (02) : 213 - 221
  • [19] Therapeutic role of rituximab in the treatment of intravascular large B-cell lymphoma
    Dognini, G. P.
    Ponzoni, M.
    Doglioni, C.
    Martelli, M.
    Ambrosetti, A.
    Rossi, G.
    Federico, M.
    Candoni, A.
    De Renzo, A.
    Bairey, O.
    Szomor, A.
    Horvath, B.
    Uziel, L.
    Seymour, J.
    Willemze, R.
    Ferreri, A. J. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 186 - 186
  • [20] COST-MINIMISATION ANALYSIS OF SUBCUTANEOUS VS INTRAVENOUS RITUXIMAB FOR THE TREATMENT OF FOLLICULAR LYMPHOMA AND DIFFUSE LARGE B-CELL LYMPHOMA IN SINGAPORE
    Choi, M. H.
    Lim, S.
    Wong, A.
    VALUE IN HEALTH, 2018, 21 : S16 - S16
12345